论文部分内容阅读
目前,原始细胞增多的难治性贫血(RAEB)的治疗仍处探索阶段,我院试用小剂量高三尖杉酯硷疗法治疗2例,效果较好,报告如下。
Currently, the treatment of refractory anemia (RAEB) is still in its exploratory stage. Two cases of low dose HSTT treated in our hospital were treated with good results. The report is as follows.